Cargando…
Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients
BACKGROUND: Fibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in regulating the secretory activity of islet beta cells in patients with type 2 diabetes. This study aimed to evaluate the relationship between the levels of serum FGF19 and endo...
Autores principales: | Tang, Meng-jie, Su, Jian‑bin, Xu, Tian-li, Wang, Xue‑qin, Zhang, Dong-mei, Wang, Xiao-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6760053/ https://www.ncbi.nlm.nih.gov/pubmed/31572498 http://dx.doi.org/10.1186/s13098-019-0475-1 |
Ejemplares similares
-
Inverse relationship between serum adenosine deaminase levels and islet beta cell function in patients with type 2 diabetes
por: Cao, Jie, et al.
Publicado: (2021) -
Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes
por: Liu, Wang-shu, et al.
Publicado: (2020) -
Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes
por: Wang, Hong, et al.
Publicado: (2021) -
Serum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes
por: Zhuang, Lei, et al.
Publicado: (2016) -
Islet Regeneration: Endogenous and Exogenous Approaches
por: Docherty, Fiona M., et al.
Publicado: (2021)